AB0360 EVALUATION OF HEALTHCARE RESOURCE UTILISATION AND COSTS OF SJöGREN’S SYNDROME: PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT OR ANTI-TNF DMARDS

Volume: 78, Pages: 1636 - 1636
Published: Jun 1, 2019
Abstract
Background null Sjogren’s syndrome (SS) is considered an extra-articular manifestation of RA and is an autoantibody-mediated condition similar to RA. In an open-label, prospective, observational multicentre study, abatacept (ABA) was found to be effective for both RA and SS-related manifestations.1 However, there are limited data on the healthcare resource utilisation (HCRU) and cost in patients (pts) with RA with SS managed with ABA compared...
Paper Details
Title
AB0360 EVALUATION OF HEALTHCARE RESOURCE UTILISATION AND COSTS OF SJöGREN’S SYNDROME: PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT OR ANTI-TNF DMARDS
Published Date
Jun 1, 2019
Volume
78
Pages
1636 - 1636
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.